SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-126424
Filing Date
2005-06-16
Accepted
2005-06-16 15:44:49
Documents
9
Period of Report
2005-06-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 61585
2 FORM OF INCENTIVE STOCK OPTION GRANT AGREEMENT dex102.htm EX-10.2 30404
3 FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT dex103.htm EX-10.3 27518
4 FORM OF DIRECTOR'S NONQUALIFIED STOCK OPTION GRANT AGREEMENT dex104.htm EX-10.4 38377
5 FORM OF STOCK APPRECIATION RIGHT GRANT AGREEMENT dex105.htm EX-10.5 27266
6 FORM OF STOCK AWARD GRANT AGREEMENT dex106.htm EX-10.6 21958
7 PRESS RELEASE dex991.htm EX-99.1 10305
8 GRAPHIC g68757img1.jpg GRAPHIC 14174
9 GRAPHIC g68757img2.jpg GRAPHIC 3778
  Complete submission text file 0001193125-05-126424.txt   244059
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-31577 | Film No.: 05900278
SIC: 2834 Pharmaceutical Preparations